chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Initial report received from a nurse on 14 December 2006. A 55 year old, female patient (with a history of allergy to PCN) developed a large 'budge" in her neck - left side clavicle bone and her shoulder was large, red and warm at the injection site, the next morning after she received Fluzone (lot number U2550AA) intramuscularly in the left deltoid on 12 December 2006. She was seen by a physician - Advil and heat were prescribed. She did not have any illness at the time of vaccination. At the time of the report, she was not recovered. Follow-up information received on 22 January 2007 from a health care professional. The patient was seen by a physician on 13 December 2006 with a chief complaint of swelling on the left side of the neck anteriorly, just under the clavicle near the left shoulder. The patient stated that she noticed the swelling that morning. She could palpate it, and it was not associated with any injury or pain. At the time of examination the swelling was noted to have extended somewhat below the clavicle near the shoulder. She had no fever, shortness of breath, wheezing, chills or rashes. She had no chest or abdominal pain. She had some general aches and pains, but no specific left-sided pain. Upon examination, the area of swelling was noted to be just lateral to the sternocleidomastoid muscle and just in front of the trapezius muscle. The swelling measured 8 x 7 cm just inferior to the clavicle. There was an area of swelling measuring 8 x 6 cm just inferior to the clavicle and laterally near the shoulder. There was no redness or warmth to either of the involved areas. No tenderness was noted. At the injection site there was some swelling and warmth. The area of swelling measured 2.5 x 3 cm. There was no lymphatic streaking or axillary lymph node involvement noted. There were no neck masses or lymph nodes noted. There was no thyromegaly. The patient was advised to use Aleve and apply ice to the involved areas. No laboratory tests or diagnostics were performed. The events lasted for one week. The patient has recovered from the events. Additional information is not anticipated.
Gave a vaccine to two patients that was past the 12hr window; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Gave a vaccine to two patients that was past the 12hr window) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017E21A and 091D21A) for COVID-19 vaccination.     Concurrent medical conditions included Adhesive tape allergy (tape), Allergy to antibiotic (Amoxicillin) and Allergy to antibiotic (Erythromycin).   On 24-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Gave a vaccine to two patients that was past the 12hr window). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Gave a vaccine to two patients that was past the 12hr window) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were provided by the reporter  No treatment medication were provided by the reporter   Most recent FOLLOW-UP information incorporated above includes: On 23-Aug-2021: Follow up received on 23 Aug 2021 include reporter first name updated. On 25-Aug-2021: Follow up received on 25 Aug 2021 include no new information. On 25-Aug-2021: Follow-up received on 25 Aug 2021 include patient demographics.
12-6-05 client received Td in LDT/IM for College requirement. 12-8-05 client return to HD and LDT area is swollen and red. 5x5 cm area of erythema and swelling. RX: Dexamethasone 8mg in RDT IM     Cipro 500 mg Bid x 7 days     If swelling persist start Medrol dose pack
Had 3 - 4 cm papular rash at MMR site. Had multiple 1 - 2 cm red w/central blister -> pustule d #1 of rash (10/27). Has erythema/swelling c/w allergic response.
Pt recv vax on 1/7/99; on same day pt exp red dot rash on back, chest, neck, legs-urticaria w/ itching; tx=Solumedrol, Benadryl Elixir
PT DEVELOPED HIVES AND RASHES 3 WEEKS AFTER SMALLPOX ADMINISTRATION
Excruciating pain in the knee joints down to feet.  Took about 10 days to function somewhat.  Still have constant pain.
Patient on Enbrel since 2016 reports anaphylactic reaction to 1st Pfizer Covid vaccine 3/27/2021. Has not had any additional covid vaccinations. Also reports diagnosed with covid Nov 1, 2021 and was hospitalized 5 days for that.
A territory representative reported that a 7 month old female received her 2nd dose of Prevnar and subsequently was diagnosed with Streptococcus Pneumoniae bacteremia. No further information was available at the date of this report. Streptococcal septicemia is considered medically important.
See previous submission for details (VAERS E-Report No: 165559 of 2019-04-30). Briefly, severe ringing in the ears followed by flu like symptoms and fatigue. I took Tylenol 600 mg at 10:30 AM and 6:30 PM. The symptoms lasted approximately 10 to 12 hours starting at about 8 AM on 8/9/19. The night before my arm was quite sore and stiff about 4 to 6 hours after the shot. I slept off and on during the day on 8/9/19 and did not start to feel better until after 4 PM. I do not believe that my symptoms were as severe as the first reaction, but were enough to knock me out for most of the day (sleeping).
missed the second dose /at appropriate time/ first dose was administered on 17Sept2019 /second dose has not been administered; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 77-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 17th September 2019 with batch number 3FJ59 and expiry date 27th November 2021).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional information was provided as follows: The age at vaccination was not applicable for this report. The patient missed the second dose of Shingrix at appropriate time and did not receive it till the time of reporting which led to incomplete course of vaccination. VAERS details were reported for 1st dose of Shingrix. The reporter consented to follow up via email. This case has been linked with US2021122641 reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021122641:same reporter
High fever and significant nausea. Discontinued treatment (did not take the 2nd & 3rd doses).
Also received COVID19 Pfizer vaccine #2 on April 5 at same location.  On July 1, client had nasal congestion and loss of taste and smell.  Tested positive PCR on 7/5 for Covid.  VAERS report submitted because client is fully vaccinated and tested positive with symptoms for Covid.
I HAD MY FIRST VACCINE ON 6 FEB 2021 AT FACILITY ABOUT 6:00PM.   THAT WAS ON A SATURDAY.  ON THE FOLLOWING TUESDAY, I HAD A PAIN IN MY LEFT ARM FROM THE INJECTION SITE DOWN THRU MY ELBOW JOINT AND CONTINUING ON TO MY LEFT WRIST.  I HAVE HAD THE PAIN EVER SINCE.  I DID NOT REALIZE THAT TIREDNESS, MUSCLE PAIN, JOINT PAIN AND FEELING UNWELL ALONG WITH DIZZINESS AND WEAKNESS  WERE SYMPTOMS OF A POSSIBLE REACTION TO THE VACCINE. SOME OF THESE SYMPTOMS COULD BE FROM A PREVIOUS STROKE.
After my 2nd dose administration, I sat in an observation tent with 4 resident doctors. This is protocol at my hospital to assess for any adverse reactios. About 10 minutes later, I started to feel both of my arms (from should all the way to tips of my fingers) start to get tingly with an intense vibrating sensation. I tried to calm myself down, however numbness began to occur to both BUE seconds after. Next thing that happened, bilateral fingers became visually contracted however numb and I could not move my fingers. I also got a tingly/prickly sensation to my cheeks all the way down to my chin after the hand numbess. The resident doctors quickly took me by wheelchair to a private room where they checked my vital signs. BP was elevated with systolic in 190's, HR around 120s, and my limbs were all cold. By this time it was around 6pm and they were trying to calm me down as I started to have a panic attack. My parents came to pick me up at 7pm when my vitals were stable. I rested at home, and the contraction to my fingers/numbess did not subside until 8:30pm.  The following day, my left arm (injection site) had a soreness level of 9/10. Tylenol was used to relieve pain.
On 8/28/21 and 8/29/21, our child reported very mild shortness of breath and mild chest pain.  At 2am on the morning of 9/1/21, he awoke with what he described as severe chest pain.  There was no shortness of breath, and, while concerned, we decided not to seek emergency medical care at that time.  We gave a dose of ibuprofen.  The symptoms slowly abated, but did not disappear over about 2 hours, at which point he was able to go back to sleep.  By morning he had no symptoms and felt fine, but because the symptoms had been worrying we called our pediatrician's office first thing.  Child was seen at about 9am, and referred for an EKG and chest X-ray, which he received the morning of 9/2/21.  Both tests were normal.  Our pediatrician took the symptoms seriously but did not believe they were connected to vaccine, in part because three weeks had passed since the second dose.  We however have never been sure so decided to submit a VAERS report at this time.  Our child has not experienced these symptoms again and has been healthy as far as we can tell, participating normally in school and sports.
Initial symptoms: tiredness, dizziness, overall muscular soreness, sense of impending doom (never had any of that before) More recent symptoms - starting 9/15/2021: on a routine health check, doctor noted uptick in PVCs. Subsequent EKG was normal. I've avoided coffee since the day of the office visit. Nonetheless, PVCs continue: heart flutter, minor chest discomfort, light cough. I recognized these symptoms because I first encountered them 25 years ago. I was going to the gym a lot and drinking a "health" beverage each time. I didn't realize how much Ephedrine it contained. Once I stopped using it, symptoms disappeared. So this is new.
I started feeling chills, sneezed and had cold symptoms: stuffy nose, body aches and slight fever. I took an at home test, which was positive. So, I went to urgent care and they tested me again to confirm I was positive. They told me to isolate for about 5 days and take Tylenol for pain, and rest. I was told to communicate with my doctor, which I did through texting. He said he agreed with my regimen and told me that if it worsened, he would prescribe something. 2 days later my congestion got worse, but my chills/fever went away, and today, which is about a week after testing positive the first time, I still test positive. I still am slightly congested and fatigued. My appetite is off but really just feels like having a bad cold. I was told by urgent care and my PCP to add Zinc to my regimen to help boost my immune system.
excruciating pain that goes shooting across his face into his jaw; excruciating pain that goes shooting across his face into his jaw; Eye pain; Exhausted; Entire body started hurting; Consistent Migraine; Back hurts (not sure if it is back or kidneys); Left eye pressure and excruciating pain (into his upper cheekbone).  It is like an electric jolt.; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Consistent Migraine), BACK PAIN (Back hurts (not sure if it is back or kidneys)), OCULAR DISCOMFORT (Left eye pressure and excruciating pain (into his upper cheekbone).  It is like an electric jolt.), PAIN IN JAW (excruciating pain that goes shooting across his face into his jaw) and FACIAL PAIN (excruciating pain that goes shooting across his face into his jaw) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jul-2021, the patient experienced MIGRAINE (Consistent Migraine), BACK PAIN (Back hurts (not sure if it is back or kidneys)), OCULAR DISCOMFORT (Left eye pressure and excruciating pain (into his upper cheekbone).  It is like an electric jolt.), FATIGUE (Exhausted) and MYALGIA (Entire body started hurting). On an unknown date, the patient experienced PAIN IN JAW (excruciating pain that goes shooting across his face into his jaw), FACIAL PAIN (excruciating pain that goes shooting across his face into his jaw) and EYE PAIN (Eye pain). At the time of the report, MIGRAINE (Consistent Migraine), BACK PAIN (Back hurts (not sure if it is back or kidneys)), OCULAR DISCOMFORT (Left eye pressure and excruciating pain (into his upper cheekbone).  It is like an electric jolt.), PAIN IN JAW (excruciating pain that goes shooting across his face into his jaw), FACIAL PAIN (excruciating pain that goes shooting across his face into his jaw), EYE PAIN (Eye pain), FATIGUE (Exhausted) and MYALGIA (Entire body started hurting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications and treatment medications were reported.
Breakthrough case after 2 vaccines Janssen 4/5/21 Lot# 043A21A;  Moderna 1/19/22 Lot# 066H21A
Itch; she broke out in spots that are red and raised up; This is a spontaneous report from a contactable consumer or other non hcp.  A 76-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Right on 21Jan2021 16:00 (Batch/Lot Number: EL3246) as 1ST DOSE, SINGLE DOSE, dose 2 via an unspecified route of administration, administered in Arm Right on 11Feb2021 16:00 (Batch/Lot Number: EM9810) as 2ND DOSE, SINGLE DOSE for covid-19 immunisation (COVID Prevention). Medical history included Allergic to Shellfish. The patient's concomitant medications were not reported. It was reported that on 22Jan2021 patient broke out in spots that are red and raised up. Reporter was calling about his wife. Reporter states that his wife broke out just a little with the first dose of the product, and with the second shot she broke out in 5 or 6 spots on her belly that are maybe an inch around, and raised up, like pumped up, and her skin is turning red. Reporter clarified the suspect product as the Pfizer COVID Vaccine. Reporter was wondering if this was a normal reaction. Reporter informed that the patient was 76 after the first dose of the product, and 77 when she received the second dose. It was also reported that the patient got her first dose of the product on 21Jan2021, and the spots appeared the next day. Caller reports that they thought they got bed bugs because the spots look like little bites, like welts that stay for two or three days and then they go down. Caller informs that the patient got the second dose on 11Feb2021 and the spots appeared again the day after the injection, and caller confirms they are ongoing and persisting. reporter was wondering how long the spots will last. Caller reports the patient saw a dermatologist and was given a cream. Caller also stated that patient has been using rubbing alcohol on the spots to help the itch. Reporter also stated that his brother, sister and sister-in-law have all received the vaccine and no one else has broken out so far. Patient not having previous doses of the COVID-19 vaccine prior to 21Jan2021. Outcome of the event Itch was unknown. Outcome of the other event was not recovered.  No follow up attempts are possible. No further information is expected.
COVID-19 Treatment; COVID-19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP).  A 39-year-old male patient received BNT162b2 (BNT162B2), on 02Nov2021 as dose 1, single (Batch/Lot number: unknown) at the age of 38 years for covid-19 immunisation. The patient's relevant medical history included: "HIV" (unspecified if ongoing), notes: HIV. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: On an unknown date in Dec2022, the patient had COVID-19. The patient received as anti-viral for COVID-19 treatment from 02Dec2022 to 07Dec2022.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: As there is limited information in the case provided, the causal association between the reported events with the suspect drug BNT162B2 cannot be excluded. The case will be reassessed once new information is available.
This is a spontaneous report from a Physician who reported for 3 patients and from a nurse via a sales representative. This is the first of three reports.  A patient of unspecified age, gender and ethnicity received a single dose of PREVNAR13 at single dose on unspecified date. Patient medical history and concomitant mediations were not reported. On unknown date the patient experienced swelling of arm, redness and pain. The outcome of the events was unknown. One of the patients called back to the doctors office to report the side effects and took a picture to show the reaction and sent it to the office. According to the reporter there was a reasonable possibility that this events were related to the suspect product. Follow-up (06MAR2015): Follow-up attempts completed. No further information expected.
100 degree Fahrenheit temperature for 24 hours; tired feeling; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (100 degree Fahrenheit temperature for 24 hours) and FATIGUE (tired feeling) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046A214 and 001A21A) for COVID-19 vaccination.     The patient had no allergies and had not been tested positive or diagnosed with COVID-19.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced PYREXIA (100 degree Fahrenheit temperature for 24 hours) and FATIGUE (tired feeling). In 2021, PYREXIA (100 degree Fahrenheit temperature for 24 hours) had resolved. At the time of the report, FATIGUE (tired feeling) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Body temperature: 100 degree fahrenheit (High) 100 degree Fahrenheit for 24 hours.         No concomitant medications were reported. No treatment information was provided.  The patient's husband described the adverse events as a reaction to the second dose of the vaccine.   This case was linked to MOD-2022-544448, MOD-2022-544443, MOD-2022-544267, MOD-2022-544281 (Patient Link).
Upper left arm where shot was administered is still sore 6 months later. Sometimes hurts so bad at night it wakes me up and have difficult time falling back to sleep because of the pain.
Sweating; "Feels clammy"; Nausea; Elevated blood pressure (189/112 and Pulse 76); Dizziness
patient became light headed and nauseous shortly after administration.  Her respiration was free and normal but was given a dose of oral benadryl at fathers request. She was also given water and was back to normal with in 10 mins.
fever of 103 & localized erythema rxn w/in 2hr p/5th dose;12JUL95 temp 100;
Mom called and stated that child had redness and slight swelling but no fever. Noted site of injection is not sore when depressed. Mom reports no other problem.
patient had left arm pain because he says the vaccine was given in the shoulder muscle not the deltoid muscle. he saw his doctor and they said it caused nerve pain. he had to miss work and see the doctor. he had a picture of where the bandaid was.
Painful and red contralateral side (right) olecranon bursitis (Ulnar Bursitis)
6cm red tender area rt triceps;t100.5 po motrin tsp q 6 hr & recheck in 24hr;31MAR97 no evidence of tenderness/redness/pain @ site;
cellulitis; Heat; Lumps; Pain; swollen; A spontaneous report  was received from a consumer who was also a 68-years-old, female patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and who experienced cellulitis, heat/ vaccination site warmth , lumps/ oedema, pain and swelling.  The patient's medical history was not provided.   Products known to have been used by the patient, within two weeks prior to the event, included Aspirin, Metformin, Vivo, Thyroxine, Metoprolol, Omeprazole, Singulair, Oxygen, B12 Injection, Flaxseed Oil, Cocu10, Libutrin, Evox, Alogliptin Calcium Citrate and Vitamin B/C/D nonspecific.  On 19 Jan 2021, the patient received their first of two planned doses of mRNA-1273 (Batch number: 027620A) intramuscularly in the hip for prophylaxis of COVID-19 infection.  On 24 Feb 2021, prior to the onset of the symptoms, the patient received their second of two planned doses of mRNA-1273 (Batch number: 002A219A) intramuscularly in the hip for prophylaxis of COVID-19 infection.   On unspecified dates, following each of the injections the patient developed cellulitis, heat, lumps, painful and was swollen. On the most recent injection the patient has a lump that was 6 inhes by 2 inches in size. Some side effects are still present at the time of reporting.   Treatment for the event included Keflex both times and heat pad nonspecific.  The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the drug in response to the events is not applicable.  Outcome of the events of cellulitis, heat, lumps, pain and swelling was unknown at the time of this report.; Reporter's Comments: This case concerns a 68-year-old female who had a serious unexpected event of cellulitis along with nonserious unexpected vaccination site warmth, swelling, edema, and pain. Event onset occurred with unknown latency after the second dose of mRNA-1273. Treatment included Keflex. Event outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
J96.00 ACUTE RESPIRATORY FAILURE 3/25/2023 ASTHMA, UNSPECIFIED
First, I DO NOT KNOW if the reaction is related to the vaccine.  The vaccine was administered on Friday around 6:00PM at Pharmacy. Starting on Saturday, I had chills, fatigue, and other minor symptoms similar to prior administrations of this vaccine.  These continued through Sunday.  On Monday, I had digestive issues including frequent, loose bowel movements and ?acid? stomach which continued on Tuesday.  I did not experience these symptoms on Doses 1-4.  On Wednesday, my smart watch alerted me that I was likely having atrial fibrillation.  I felt somewhat weak, fatigued.  We left for the ED where it was confirmed that I was in atrial fibrillation.  Diltiazem was administered and successfully reduced the afib.  I have never had afib before.  Meds prescribed included Diltiazem 180mg once daily and Eloquis 5mg BID.  I do not show any afib symptoms today.  The GI symptoms stopped on Wednesday.